Barriers to optimizing inflammatory bowel disease care in the United States

被引：7
|
作者：
Spencer, Elizabeth A. [2 ]
Abbasi, Sadeea [3 ]
Kayal, Maia [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Henry D Janowitz Div Gastroenterol, One Gustave L Levy Pl Box 1069, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Pediat Gastroenterol, New York, NY USA
[3] Cedars Sinai Santa Monica Gastroenterol, Div Gastroenterol, Santa Monica, CA USA
来源：
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY | 2023年 / 16卷
基金：
美国国家卫生研究院;
关键词：
barriers; inflammatory bowel disease; insurance; HEALTH-CARE; MANAGEMENT; GUIDELINE; THERAPY;
D O I：
10.1177/17562848231169652
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Significant progress in the management and modification of inflammatory bowel disease (IBD) has been made; however, significant barriers to the optimization of IBD care in the United States still exist. The majority of these barriers are constructed by insurance carriers and the integration of market pressures into healthcare decision-making. In this review, we highlight the barriers to IBD care optimization within the context of the US insurance system and review current and proposed solutions.
引用
收藏
页数：14
相关论文
共 50 条
  • [21] Optimizing Thiopurine Therapy in Inflammatory Bowel Disease
    Chevaux, Jean-Baptiste
    Peyrin-Biroulet, Laurent
    Sparrow, Miles P.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (06) : 1428 - 1435
  • [22] Optimizing immunomodulator therapy for inflammatory bowel disease
    Marla C. Dubinsky
    Current Gastroenterology Reports, 2003, 5 (6) : 506 - 511
  • [23] High Prevalence of Inflammatory Bowel Disease in United States Residents of Indian Ancestry
    Malhotra, Reenu
    Turner, Kevin
    Sonnenberg, Amnon
    Genta, Robert M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (04) : 683 - 689
  • [24] Dietary Intake of Pregnant Women with and without Inflammatory Bowel Disease in the United States
    Olendzki, Barbara C.
    Hsiao, Bi-Sek
    Weinstein, Kaitlyn
    Chen, Rosemary
    Frisard, Christine
    Madziar, Camilla
    Picker, Mellissa
    Pauplis, Connor
    Maldonado-Contreras, Ana
    Peter, Inga
    NUTRIENTS, 2023, 15 (11)
  • [25] Nine Medico-Legal Pitfalls in Inflammatory Bowel Disease in the United States
    Tremaine, William J.
    CURRENT DRUG TARGETS, 2014, 15 (11) : 1039 - 1041
  • [26] Comparative Incidence of Inflammatory Bowel Disease in Different Age Groups in the United States
    Keyashian, Kian
    Dehghan, Melody
    Sceats, Lindsay
    Kin, Cindy
    Limketkai, Berkeley N.
    Park, K. T.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (12) : 1983 - 1989
  • [27] The effectiveness of continuity of care in patients with inflammatory bowel disease: a systematic review
    Gu, Zijun
    Gu, Junyi
    Liu, Ping
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [28] Racial/Ethnic and Regional Differences in the Prevalence of Inflammatory Bowel Disease in the United States
    Wang, Yize R.
    Loftus, Edward V., Jr.
    Cangemi, John R.
    Picco, Michael F.
    DIGESTION, 2013, 88 (01) : 20 - 25
  • [29] Optimizing quality of outpatient care for patients with inflammatory bowel disease: the importance of specialist clinics
    Mawdsley, Joel E. D.
    Irving, Peter M.
    Makins, Richard J.
    Rampton, David S.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (03) : 249 - 253
  • [30] Models of Care for Inflammatory Bowel Disease: A National Cross-sectional Survey to Characterize the Landscape of Inflammatory Bowel Disease Care in Canada
    Miles, Matthew
    Pena-Sanchez, Juan Nicolas
    Heisler, Courtney
    Cui, Yunsong
    Mathias, Holly
    Stewart, Michael
    Jones, Jennifer L.
    CROHNS & COLITIS 360, 2022, 4 (04)
12345